Dendritic Cells Control CD4+CD25+ Treg Cell Suppressor Function In Vitro through Juxtacrine Delivery of IL-2

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kulhankova, Katarina ^b   Rouse, Todd ^a   Nasr, Mohamed E ^a   Field, Elizabeth H ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; CYTOPLASM PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANTIGEN FUNCTION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL CONTACT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EPIFLUORESCENCE MICROSCOPY; FLOW CYTOMETRY; IN VITRO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD4; CELL COMMUNICATION; CELL PROLIFERATION; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC;

EID: 84866313177     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043609     Document Type: Article

References (79)

1. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27.
2. Wood KJ, Sakaguchi S, (2003) Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3: 199-210.
3. Schulze Zur Wiesch J, Thomssen A, Hartjen P, Tóth I, Lehmann C, et al. (2011) Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol 85: 1287-1297.
4. Curiel TJ, (2008) Regulatory T cells and treatment of cancer. Curr Opin Immunol 20: 241-246.
5. Welters MJ, Kenter GG, de Vos van Steenwijk PJ, Löwik MJ, Berends-van der Meer DM, et al. (2010) Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses. Proc Natl Acad Sci U S A 107: 11895-11899.
6. Riley JL, June CH, Blazar BR, (2009) Human T regulatory cells as therapeutic agents: Take a billion or so of these and call me in the morning. Immunity 30: 656-665.
7. Shuntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, et al. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355: 1018-1028.
8. Brusko T, Bluestone J, (2008) Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation. Eur J Immunol 38: 931-934.
9. Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, et al. (2009) Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58: 652-662.
10. Battaglia M, Roncarolo MG, (2011) Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. Semin Immunol 23: 182-194.
11. Feng G, Wood KJ, Bushell A, (2008) Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation 86: 578-589.
12. Tang Q, Bluestone JA, Kang SM, (2012) CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol 4: 11-21.
13. Edinger M, Hoffmann P, (2011) Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. Curr Opin Immunol 23: 679-684.
14. Bruno L, Merkenschlager M, (2008) Directing T cell differentiation and function with small molecule inhibitors. Cell Cycle 7: 2296-2298.
15. Brusko TM, Putnam AL, Bluestone JA, (2008) Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 223: 371-390.
16. Ruter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, et al. (2009) Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. Front Biosci 14: 1761-1770.
17. Welters MJ, Piersma SJ, van der Burg SH, (2008) T-regulatory cells in tumour-specific vaccination strategies. Expert Opin Biol Ther 8: 1365-1379.
18. Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, et al. (2007) Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res 67: 7487-7494.
19. Berntsen A, Brimnes MK, thor Straten P, Svane IM, (2010) Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2. J Immunother 33: 425-434.
20. Beyer M, Schumak B, Weihrauch MR, Andres B, Giese T, et al. (2012) In vivo expansion of naive CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration. PLoS One 7: e30422.
21. Cheng G, Yu A, Malek TR, (2011) T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev 241: 63-76.
22. Barron L, Dooms H, Hoyer KK, Kuswanto W, Hofmann J, et al. (2010) Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol 185: 6426-6430.
23. Smith KA, (2006) The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs. Med Immunol 5: 3.
24. Wang X, Rickert M, Garcia KC, (2005) Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 310: 1159-1163.
25. Stauber DJ, Debler EW, Horton PA, Smith KA, Wilson IA, (2006) Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci U S A 103: 2788-2793.
26. Almeida AR, Legrand N, Papiernik M, Freitas AA, (2002) Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169: 4850-4860.
27. Malek TR, Yu A, Vincek V, Scibelli P, Kong L, (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17: 167-178.
28. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Pénit C, (1998) Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10: 371-378.
29. Soper DM, Kasprowicz DJ, Ziegler SF, (2007) IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur J Immunol 37: 1817-1826.
30. Sadlack B, Löhler J, Schorle H, Klebb G, Haber H, et al. (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 25: 3053-3059.
31. Suzuki H, Kündig TM, Furlonger C, Wakeham A, Timms E, et al. (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268: 1472-1476.
32. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, et al. (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530.
33. Bayer AL, Yu A, Adeegbe D, Malek TR, (2005) Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period. J Exp Med 201: 769-777.
34. Malek TR, (2003) The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol 74: 961-965.
35. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ, (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 196: 851-857.
36. Yu A, Malek TR, (2006) Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells. J Immunol 177: 5115-5121.
37. Setoguchi R, Hori S, Takahashi T, Sakaguchi S, (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201: 723-735.
38. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
39. Barron L, Dooms H, Hoyer KK, Kuswanto W, Hofmann J, et al. (2010) Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol 185: 6426-6430.
40. Thornton AM, Donovan EE, Piccirillo CA, Shevach EM, (2004) Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172: 6519-6523.
41. de la Rosa M, Rutz S, Dorninger H, Scheffold A, (2004) Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 34: 2480-2488.
42. Wuest TY, Willette-Brown J, Durum SK, Hurwitz AA, (2008) The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J Leukoc Biol 84: 973-980.
43. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
44. Fehérvari Z, Yamaguchi T, Sakaguchi S, (2006) The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol 27: 109-111.
45. Wolf M, Schimpl A, Hünig T, (2001) Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 31: 1637-1645.
46. Sgouroudis E, Kornete M, Piccirillo CA, (2011) IL-2 production by dendritic cells promotes Foxp3+ regulatory T-cell expansion in autoimmune-resistant NOD congenic mice. Autoimmunity 44: 406-414.
47. Guiducci C, Valzasina B, Dislich H, Colombo MP, (2005) CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell-produced IL-2. Eur J Immunol 35: 557-567.
48. Zanoni I, Foti M, Ricciardi-Castagnoli P, Granucci F, (2005) TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J Immunol 175: 286-292.
49. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, et al. (2005) Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 510-517.
50. Goodridge HS, Simmons RM, Underhill DM, (2007) Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol 178: 3107-3115.
51. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, et al. (2006) Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7: 83-92.
52. Kim HP, Leonard WJ, (2002) The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements. EMBO J 21: 3051-3059.
53. Murawski MR, Litherland SA, Clare-Salzler MJ, Davoodi-Semiromi A, (2006) Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Ann N Y Acad Sci 1079: 198-204.
54. Sojka DK, Hughson A, Sukiennicki TL, Fowell DJ, (2005) Early kinetic window of target T cell susceptibility to CD25+ regulatory T cell activity. J Immunol 175: 7274-7280.
55. Thornton AM, Shevach EM, (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287-296.
56. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, et al. (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2: 882-888.
57. Granucci F, Feau S, Angeli V, Trottein F, Ricciardi-Castagnoli P, (2003) Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J Immunol 170: 5075-5081.
58. Sauma D, Michea P, Lennon-Duménil AM, Fierro A, Morales J, et al. (2004) Interleukin-4 selectively inhibits interleukin-2 secretion by lipopolysaccharide-activated dendritic cells. Scand J Immunol 59: 183-189.
59. Marguti I, Yamamoto GL, da Costa TB, Rizzo LV, de Moraes LV, (2009) Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells. Immunology 127: 50-61.
60. Chen Y, Peng Z, (2001) A sensitive in situ ELISA for quantitative measurements of cytokines and antibodies secreted by culture lymphocytes. J Immunoassay Immunochem 22: 353-369.
61. Ekerfelt C, Ernerudh J, Jenmalm MC, (2002) Detection of spontaneous and antigen-induced human interleukin-4 responses in vitro: comparison of ELISPOT, a novel ELISA and real-time RT-PCR. J Immunol Methods 260: 55-67.
62. Brinster C, Shevach EM, (2005) Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function. J Immunol 175: 7332-7340.
63. Fehérvári Z, Sakaguchi S, (2004) Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol 16: 1769-1780.
64. Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, et al. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198: 235-247.
65. Suffner J, Hochweller K, Kühnle MC, Li X, Kroczek RA, et al. (2010) Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J Immunol 184: 1810-1820.
66. Darrasse-Jèze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, et al. (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 206: 1853-1862.
67. Koenen HJ, Fasse E, Joosten I, (2003) IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. J Immunol 171: 6431-6441.
68. Piccirillo CA, Thornton AM, (2004) Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 25: 374-380.
69. Ohkura N, Sakaguchi S, (2010) Regulatory T cells: roles of T cell receptor for their development and function. Semin Immunopathol 32: 95-106.
70. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S, (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A 105: 10113-10118.
71. Muthuswamy R, Urban J, Lee JJ, Reinhart TA, Bartlett D, et al. (2008) Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res 68: 5972-5978.
72. Hémar A, Subtil A, Lieb M, Morelon E, Hellio R, et al. (1995) Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J Cell Biol 129: 55-64.
73. Yu A, Malek TR, (2001) The proteasome regulates receptor-mediated endocytosis of interleukin-2. J Biol Chem 276: 381-385.
74. Kalantari T, Kamali-Sarvestani E, Ciric B, Karimi MH, Kalantari M, et al. (2011) Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol Res 51: 153-160.
75. Murphy KM, Heimberger AB, Loh DY, (1990) Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250: 1720-1723.
76. Liu CP, Kappler JW, Marrack P, (1996) Thymocytes can become mature T cells without passing through the CD4+ CD8+, double-positive stage. J Exp Med 184: 1619-1630.
77. Rigby SM, Rouse T, Field EH, (2003) Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells. Blood 101: 2024-2032.
78. Yui MA, Hernández-Hoyos G, Rothenberg EV, (2001) A new regulatory region of the IL-2 locus that confers position-independent transgene expression. J Immunol 166: 1730-1739.
79. Yui MA, Sharp LL, Havran WL, Rothenberg EV, (2004) Preferential activation of an IL-2 regulatory sequence transgene in TCR gamma delta and NKT cells: subset-specific differences in IL-2 regulation. J Immunol 172: 4691-4699.